Unihealth Hospitals (UNIHEALTH) Q2 FY27 Profit Slumps 25% Despite Strong Revenue Growth
The hospital chain's revenue jumped 15% year-on-year, but a sharp rise in costs for its new Indian facilities pushed net profit down by a quarter.
Unihealth Hospitals posted a 14.7% rise in Q2 FY27 revenue to ₹76.44 crore. However, profit fell 24.8% to ₹21.52 crore as costs from new hospitals in Navi Mumbai and Nashik squeezed margins.
For Unihealth Hospitals, the September quarter was a story of two geographies. The company's mature, high-margin hospital in Uganda continued to drive the top line, while its aggressive expansion in India began to weigh heavily on the bottom line.
The numbers show the tension clearly. Revenue grew 14.7% year-on-year to ₹76.44 crore, but net profit fell 24.8% to ₹21.52 crore. The net profit margin contracted sharply to 28.2%, down from 42.9% a year ago.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ2 FY27 | Same quarter LYQ2 FY26 |
|---|---|---|
| Revenue (₹ Cr) | 76.44YoY +15% | 66.67 |
| Profit (₹ Cr) | 21.52YoY -25% | 28.63 |
| Net Profit Margin | 28.2%YoY -34% | 42.9% |
The Cost of New Beds
The margin squeeze was driven by the ramp-up of new hospitals in India. Total expenses surged 48.7% year-on-year, with employee costs up 54% and interest expense jumping 55.7%. According to a report from SectorAlpha, this reflects the fixed costs of new facilities in Navi Mumbai and Nashik loading onto a still-small Indian revenue base.
Management had targeted operational breakeven at the Navi Mumbai hospital by September 2026. The sequential profit recovery of 25.9% suggests some progress, but the year-on-year comparison reveals the full weight of the expansion. A tax credit of ₹3.29 crore, linked to a Ugandan tax holiday for exporters, provided a buffer that kept the quarterly profit from falling further.
Outlook Hinges on Occupancy
The near-term story depends on filling these new beds. In a June 2026 earnings call, Managing Director Akshay Parmar said the company aims for over 500 commissioned beds by FY27-end, targeting revenue of ₹250-300 crore. The Arthneeti website notes management expects 30-40% growth in coming quarters from a low baseline.
However, the path to profitability in India is steep. New hospitals typically take 9-12 months to reach 50% occupancy. Until occupancy at Navi Mumbai and the newly opened Nashik hospital rises meaningfully, these units will continue to dilute the strong margins from the mature Ugandan operation, which contributed about 79% of FY26 revenue.
Key Points
- Revenue growth of 14.7% YoY was overshadowed by a 24.8% drop in net profit, highlighting a severe margin squeeze.
- The contraction was driven by a 48.7% surge in total expenses, primarily from staffing and financing new hospitals in Navi Mumbai and Nashik.
- Profit improved 25.9% sequentially, aided by a tax credit, indicating some early ramp-up progress.
- The investment case now turns on how quickly the new Indian facilities can reach breakeven occupancy and stop diluting consolidated margins.
Hexa Perspective
Unihealth is in a classic expansion phase where top-line growth tells only half the story. The 1,470-basis-point year-on-year margin crash shows the cost of building for the future is being paid now. The sequential margin improvement is a tentative green shoot, but not yet a trend.
The next few quarters will test whether the Ugandan cash cow can fund the Indian build-out without further eroding shareholder returns. Investors are effectively financing a bet that Indian occupancy will climb fast enough to offset the current cost drag before patience runs thin. The stock's 225% one-year return already prices in significant success, leaving little room for execution delays.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
